Evidence map›Paper›PMID 40093344›Full record

ArticleThe Pan African medical journal2024

Knowledge, attitude, and perception on COVID-19 vaccine acceptance: cross-sectional study among Eritrean refugees in Kampala.

Robel Tesfahiwet Enghida, Tesfaldet Habtemariam Hidru

Abstract read
In one paragraph

Article in The Pan African medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Robel Tesfahiwet EnghidaCavendish University Uganda, Kampala, Uganda.
Tesfaldet Habtemariam HidruDalian Medical University, Dalian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: the impact of Coronavirus disease (COVID-19) on public health has been significant and wide-ranging. It has led to widespread illness, strain on healthcare systems, and various public health measures to control its spread. Several pharmaceutical companies, researchers, and scientists have been racing against the clock to develop a safe and effective vaccine against COVID-19 in a short period. Despite the efforts by governments, organizations, and public health experts to reach the target population, vaccine hesitancy among the communities remains a major impediment to mitigating the COVID-19 pandemic. A strategy to address the factors that contribute to low vaccine utilization must be in place for a vaccination program to achieve herd immunity. Methods: a cross-sectional descriptive survey of 383 study participants was conducted between February 26 Results: according to the findings of this study, 65.8% of Eritrean refugees in Kampala were willing to accept the COVID-19 vaccine. The study discovered that marital status, knowledge of COVID-19, positive attitude toward the COVID-19 vaccine, and belief in conspiracy theories are the independent factors that are associated with vaccine acceptance behavior among refugees. Conclusion: there was a low likelihood of accepting the COVID-19 vaccine in this study. Thus, stakeholders must work together to educate the public about the COVID-19 vaccine. The health authority must inform the public about the vaccine's benefits while also addressing the vaccine's side effects and safety concerns.

Indexed as

COVID-19COVID-19 VaccinesHealth Knowledge, Attitudes, PracticePatient Acceptance of Health CareRefugeesVaccination HesitancyAdolescentAdultAgedCross-Sectional StudiesEritreaFemaleHumansMaleMiddle AgedSurveys and QuestionnairesCOVID-19 VaccinesCOVID-19knowledgerefugeesvaccine acceptance

Identifiers

PMID40093344
PMCPMC11907718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.